Other technical consultancy
NESARUS AS
Revenue 2025
NOK 0
Operating profit
NOK −9,000
Equity
NOK −218,000
Incorporated
2002
Share capital
NOK 125,000
Roles
Regnskapsfører
Styrets lederSvein Gleditsch
StyremedlemRune Gleditsch
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| Svein Gleditsch | 50.0% | 62500.000000 | 2025 |
| HONG YUAN DUAN | 50.0% | 62500.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| LYTIX BIOPHARMA ASA | Active | 0.1% | 40000.000000 |
| PHARMASUM THERAPEUTICS AS | Active | 0.0% | 896.000000 |
| AMICOAT AS | Active | 0.0% | 9512.000000 |
| PHARMA HOLDINGS AS | Active | 0.0% | 190.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.